German Oncology Center, Cyprus
Clinical trials sponsored by German Oncology Center, Cyprus, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Shorter hormone therapy meets precision radiation in High-Risk prostate cancer Results expected Oct 2026 (estimated)
- New scans could sharpen prostate cancer detection Results expected Jan 2027 (estimated)
- Five-Fraction radiation plus hormone therapy tested against High-Risk prostate cancer Results expected Aug 2027 (estimated)
-
Five-Fraction radiation plus hormone therapy tested against High-Risk prostate cancer
Disease control Recruiting nowResearchers are testing a treatment plan for men with high-risk localized prostate cancer that combines whole-pelvis radiation given in five sessions, a high-dose radiation boost directly to the prostate, and two years of androgen deprivation therapy. The study aims to see how of…
Phase 2 • Sponsor: German Oncology Center, Cyprus • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Shorter hormone therapy meets precision radiation in High-Risk prostate cancer
Disease control Recruiting nowResearchers are testing whether men with high-risk localized prostate cancer can safely receive a shorter course of hormone therapy alongside focused, dose-escalated radiation to the prostate. The trial enrolls 30 men and uses an AI-based classifier to help tailor treatment. All …
Phase 2 • Sponsor: German Oncology Center, Cyprus • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New scans could sharpen prostate cancer detection
Diagnosis Recruiting nowThis study tests two advanced imaging techniques, PSMA PET/CT and MRI-RSI, against the standard MRI to see which finds and outlines prostate tumors most accurately. Fifty men with newly diagnosed, higher-risk prostate cancer will undergo all scans and a targeted biopsy. The goal …
Sponsor: German Oncology Center, Cyprus • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC